BIOMAT Database Logo BIOMAT Database Logo

Penbutolol: a new beta blocker in the treatment of moderate essential hypertension. 1979

J L Cangiano, and J M Ayala, and I J Boksay, and M Martinez-Maldonado

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010394 Penbutolol A nonselective beta-blocker used as an antihypertensive and an antianginal agent. Betapressin,Hoe-893d,Penbutolol Sulfate,Penbutolol Sulfate (2:1),Hoe 893d,Hoe893d,Sulfate, Penbutolol
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J L Cangiano, and J M Ayala, and I J Boksay, and M Martinez-Maldonado
Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
February 1994, American journal of hypertension,
J L Cangiano, and J M Ayala, and I J Boksay, and M Martinez-Maldonado
Penbutolol in the treatment of mild to moderate essential hypertension in black South Africans.
June 1990, Journal of clinical pharmacology,
J L Cangiano, and J M Ayala, and I J Boksay, and M Martinez-Maldonado
[Effect of penbutolol (HOE 893 d), a non-selective beta blocker, in the control of essential arterial hypertension].
February 1983, Medicina clinica,
J L Cangiano, and J M Ayala, and I J Boksay, and M Martinez-Maldonado
ACE inhibitor versus beta-blocker in the treatment of essential hypertension.
January 1987, Nephron,
J L Cangiano, and J M Ayala, and I J Boksay, and M Martinez-Maldonado
[Nadolol, a long-acting beta-blocker, in the treatment of essential arterial hypertension].
September 1982, Cardiologia (Rome, Italy),
J L Cangiano, and J M Ayala, and I J Boksay, and M Martinez-Maldonado
Penbutolol in hypertension: evaluation of a new beta-adrenergic blocking drug.
January 1980, The Medical journal of Australia,
J L Cangiano, and J M Ayala, and I J Boksay, and M Martinez-Maldonado
Transdermal beta-blocker therapy in essential hypertension.
July 1988, American journal of hypertension,
J L Cangiano, and J M Ayala, and I J Boksay, and M Martinez-Maldonado
Efficacy of long-term treatment with nipradilol, a nitroester-containing beta-blocker, in patients with mild-to-moderate essential hypertension.
January 1995, Clinical therapeutics,
J L Cangiano, and J M Ayala, and I J Boksay, and M Martinez-Maldonado
[Balanced beta--alpha-blocker treatment with carvedilol in mild-moderate arterial hypertension].
March 1996, Minerva cardioangiologica,
J L Cangiano, and J M Ayala, and I J Boksay, and M Martinez-Maldonado
[Treatment of essential mild-to-moderate arterial hypertension with once-daily penbutolol. Controlled clinical study vs atenolol].
November 1988, Minerva medica,
Copied contents to your clipboard!